Abediterol/AZD-7594

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAbediterol/AZD-7594
Drug Alias NameAbediterol+AZ13189620Abediterol/AZ13189620Abediterol+AZD-7594AZD-7594/AbediterolAZD-7594+Abediterol
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonistsGlucocorticoid receptor modulators
TargetsBeta-2 adrenergic receptorGlucocorticoid receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes AbediterolAZD-7594
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A